Condition: Cardiomyopathies · Myocarditis · Inflammatory Cardiomyopathy · Sponsor: Niguarda Hospital
Two-parallel groups randomized, single-blinded, multi-center phase III controlled trial in patients with chronic inflammatory cardiomyopathy to assess the efficacy of colchicine and associated prospective registry to assess the prognostic value of positive genetic testing in this population.
This description comes directly from the study's public registry record.
Enrico Ammirati, MD, PhD · 0264447791 · enrico.ammirati@ospedaleniguarda.it
Always discuss trial participation with your own doctor first.
| Università degli studi della Campania L.Vanvitelli e Azienda Ospedaliera Specialistica dei Colli - Ospedale Monaldi | Naples, Campania, Italy | Recruiting |
| Policlinico S.Orsola-Malpighi | Bologna, Emilia-Romagna, Italy | Recruiting |
| Azienda Sanitaria Universitaria Integrata Giuliano Isontina, Trieste | Trieste, Friuli Venezia Giulia, Italy | Recruiting |
| Presidio Ospedaliero Universitario "Santa Maria della Misericordia" | Udine, Friuli Venezia Giulia, Italy | Recruiting |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Rome, Lazio, Italy | Recruiting |
| IRCCS Ospedale San Raffaele | Milan, Lombardy, Italy | Recruiting |
| ASST Grande Ospedale Metropolitano Niguarda | Milan, Lombardy, Italy | Recruiting |
| Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino | Turin, Piedmont, Italy | Recruiting |
| Università Politecnica delle Marche e AOU Ospedali Riuniti Umberto I°-Lancisi-Salesi , Ancona | Ancona, The Marches, Italy | Recruiting |
| ASL8 Arezzo San Donato Hospital | Arezzo, Tuscany, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06158698